The Bancorp Inc (TBBK) 5.12 $TBBK The Bancorp, Inc.

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
The Bancorp Inc (TBBK) 5.12 $TBBK

The Bancorp, Inc. Reports Second Quarter 2016 Financial Results
BusinessWire - Thu Jul 28, 5:00PM CDT
The Bancorp, Inc. ("The Bancorp" (NASDAQ: TBBK), a financial holding company, today reported financial results for the second quarter 2016.
TBBK: 5.12 (-0.18)

SHAREHOLDER ALERT: Lundin Law PC Announces Ongoing Investigation Of The Bancorp Inc. And Advises Current Investors to Contact the Firm
BusinessWire - Mon Jul 18, 9:58PM CDT
Lundin Law PC announces it is investigating claims against The Bancorp Inc. ("Bancorp" or the "Company" (Nasdaq: TBBK) concerning possible violations of Delaware law.
TBBK: 5.12 (-0.18)

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Claims against The Bancorp Inc. and Advises Investors to Contact the Firm
BusinessWire - Thu Jul 14, 3:28PM CDT
Khang & Khang LLP announces that it is investigating claims against The Bancorp Inc. ("Bancorp" or the "Company" (Nasdaq: TBBK). The investigation focuses on whether the Company and its officers violated Delaware law.
TBBK: 5.12 (-0.18)

IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Investigation of The Bancorp Inc. and Advises Current Investors with Losses to Contact the Firm
BusinessWire - Tue Jul 12, 7:46PM CDT
Lundin Law PC announces it is investigating claims against The Bancorp Inc. ("Bancorp" or the "Company" (Nasdaq: TBBK) concerning possible violations of Delaware law.
TBBK: 5.12 (-0.18)

Hynes Keller & Hernandez, LLC Announces Investigations of M/A-Com Technology Solutions, Inc., Frequency Electronics Inc., and The Bancorp, Inc.
PR Newswire - Thu Jun 09, 6:08AM CDT
M/A-Com Technology Solutions Holdings, Inc. ("M/A-Com" Hynes Keller & Hernandez, LLC is investigating potential claims against the Board of Directors of M/A-Com (NASDAQ: MTSI) concerning possible breaches of fiduciary duty relating to certain improper acquisitions by M/A-Com.
MTSI: 39.84 (+0.33), FEIM: 10.72 (-0.03), TBBK: 5.12 (-0.18)

The Bancorp's Board of Directors Announces Damian Kozlowski as New CEO and President
BusinessWire - Tue May 24, 7:00AM CDT
The Board of Directors of The Bancorp, Inc. (NASDAQ: TBBK), and The Bancorp Bank, today announced that Damian Kozlowski has been appointed Chief Executive Officer of The Bancorp, Inc., President of The Bancorp Bank and a Director of the company and the bank, effective June 1, 2016. Mr. Kozlowski succeeds Interim Chief Executive Officer John C. Chrystal, who will work with Mr. Kozlowski to ensure a smooth transition. Mr. Chrystal will remain a Director of both the company and the bank.
TBBK: 5.12 (-0.18)

The Bancorp, Inc. Reports First Quarter 2016 Financial Results
BusinessWire - Thu Apr 28, 4:25PM CDT
The Bancorp, Inc. ("The Bancorp" (NASDAQ: TBBK), a financial holding company, today reported financial results for first quarter 2016.
TBBK: 5.12 (-0.18)

Bancorp Shares Up 21.7% Since SmarTrend's Buy Recommendation (TBBK)
Comtex SmarTrend(R) - Tue Apr 26, 1:16AM CDT
SmarTrend identified an Uptrend for Bancorp (NASDAQ:TBBK) on March 2nd, 2016 at $4.98. In approximately 2 months, Bancorp has returned 21.69% as of today's recent price of $6.06.
TBBK: 5.12 (-0.18)

The Bancorp Releases Finetics(TM) Studio Interview Series: "Innovation in B2B and Blockchain"
BusinessWire - Mon Mar 07, 7:00AM CST
The Bancorp, Inc. (NASDAQ: TBBK), today announces the release of its next Finetics(TM) Studio interview series: "Innovation in B2B and Blockchain" featuring Rene Lacerte, CEO and Founder, Bill.com; Chris Byrd, Executive Vice President-Healthcare Operations Officer, Evolution1; and Steve Kirsch, CEO, Token.
TBBK: 5.12 (-0.18)

New Strong Sell Stocks for February 10th
Zacks Equity Research - Zacks Investment Research - Wed Feb 10, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Wednesday
ABT: 45.31 (+0.56), BKD: 18.54 (+0.07), BOCH: 6.61 (+0.03), TBBK: 5.12 (-0.18), ADPT: 44.72 (+0.15)

The Bancorp Appoints Sepideh Behram SVP, Chief Compliance Officer
BusinessWire - Wed Feb 10, 7:00AM CST
The Bancorp (NASDAQ:TBBK) today announced the appointment of Sepideh Behram to SVP, Chief Compliance Officer. In her new role, Behram will oversee the organization's entire Compliance Risk Management Program, ensuring best-in-class consumer protection within The Bancorp and among its third-party partners and service providers.
TBBK: 5.12 (-0.18)

The Bancorp posts 4Q profit
Automated Insights - Mon Feb 01, 7:38AM CST
WILMINGTON, Del. (AP) _ The Bancorp Inc. (TBBK) on Monday reported fourth-quarter profit of $19.1 million.
TBBK: 5.12 (-0.18)

The Bancorp Releases Fourth Finetics(TM) Studio Interview Series: "The Impact of EMV on Fraud"
BusinessWire - Mon Jan 25, 7:00AM CST
The Bancorp, Inc. (NASDAQ: TBBK), today announces the release of its next Finetics(TM) Studio interview series: "The Impact of EMV on Fraud" featuring Julie Conroy, Research Director, Aite Group; Dan Rosen, Founder and General Partner, Commerce Ventures; Render Dahiya, CEO, Arroweye Solutions; and Charles Crawford, Senior Vice President, Payment Acceptance, The Bancorp.
TBBK: 5.12 (-0.18)

The Bancorp, Inc. Sets Fourth Quarter and Fiscal 2015 Financial Results Release Date and Conference Call
BusinessWire - Tue Jan 19, 3:30PM CST
The Bancorp, Inc. ("Bancorp" (Nasdaq: TBBK) today announced that it will release its fourth quarter and fiscal 2015 financial results before market hours on Monday, February 1, 2016 and invites investors and other interested parties to listen to its earnings results conference call on Monday, February 1, 2016 at 10:00 a.m. Eastern time.
TBBK: 5.12 (-0.18)

Downtrend Call Working As Bancorp Stock Falls 25.3% (TBBK)
Comtex SmarTrend(R) - Fri Jan 15, 12:29PM CST
SmarTrend identified a Downtrend for Bancorp (NASDAQ:TBBK) on December 14th, 2015 at $6.85. In approximately 1 month, Bancorp has returned 25.35% as of today's recent price of $5.11.
TBBK: 5.12 (-0.18)

Shares of TBBK Down 14.4% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Fri Jan 08, 10:03AM CST
SmarTrend identified a Downtrend for Bancorp (NASDAQ:TBBK) on December 14th, 2015 at $6.85. In approximately 4 weeks, Bancorp has returned 14.39% as of today's recent price of $5.86.
TBBK: 5.12 (-0.18)

The Bancorp Releases Third Finetics(TM) Studio Interview Series: "The Future of Faster Payments and Innovation"
BusinessWire - Thu Jan 07, 7:00AM CST
The Bancorp, Inc. (NASDAQ: TBBK), today announces the release of its next Finetics(TM) Studio interview series: "The Future of Faster Payments and Innovation" featuring Janet O. Estep, CEO, NACHA--The Electronic Payments Association; Rahul Gupta, Group President, Billing and Payments, Fiserv; Sean Rodriguez, Faster Payments Strategy Leader and Senior Vice President, Federal Reserve System; and Matt Carberry, Vice President Business Development, Payments, The Bancorp.
FISV: 110.47 (+0.11), TBBK: 5.12 (-0.18)

The Bancorp Releases Second Finetics(TM) Studio Interview Series: "Balancing Innovation with Regulatory Scrutiny"
BusinessWire - Thu Dec 17, 6:30AM CST
The Bancorp, Inc. (NASDAQ: TBBK), The Official Bank of Money20/20, today announces the release of its second Finetics(TM) Studio interview series: "Balancing Innovation with Regulatory Scrutiny" featuring Tony Craddock, Director General, Emerging Payments Association; Barrie VanBrackle, Partner and Payments Specialist, Manatt, Phelps and Phillips; Brent Warrington, CEO, Hyperwallet; Gail Ball, Executive Vice President and Chief Operating Officer, The Bancorp; and Pawneet Abramowski, Senior Vice President, Director AML & Sanctions Risk Management, The Bancorp.
TBBK: 5.12 (-0.18)

Where We Are Headed - Featured Research on Bancorp Inc., Northwest Biotherapeutics, Xerium Technologies, and BioPharmX
ACCESSWIRE - Wed Dec 16, 7:23AM CST
NEW YORK, NY / ACCESSWIRE / December 16, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Bancorp Inc. (NASDAQ: TBBK), Northwest Biotherapeutics Inc. (NASDAQ: NWBO), Xerium Technologies Inc. (NYSE: XRM) and BioPharmX Corp (NYSE: BPMX). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
NWBO: 0.44 (unch), XRM: 7.50 (+0.05), TBBK: 5.12 (-0.18), BPMX: 0.71 (-0.01)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investors Urged to Explore Rights in Symbotic Class Action

Updated Category News Views 77

Understanding the Class Action Lawsuit for Symbotic Inc. Investors in Symbotic Inc. (NASDAQ:SYM) are currently facing significant concerns regarding recent developments within the company. A class action lawsuit has been initiated in the U.S. District Court for the District of Massachusetts, aimed at those investors who purchased securities between the specified dates....

Continue Reading
Egypt's President Sisi Reflects on IMF Agreement Amid Crisis

Updated Category News Views 169

Egypt's Economic Landscape Under Scrutiny In light of unprecedented regional challenges, Egyptian President Abdel Fattah al-Sisi has raised concerns regarding the nation's ongoing agreement with the International Monetary Fund (IMF). The $8 billion financial support program, signed amidst economic turbulence, may be revisited if the expectations of global financial...

Continue Reading
Insights into Mastercard's Recent Options Trading Dynamics

Updated Category News Views 102

Mastercard's Options Activity: What's Happening? Recently, the options market has seen significant movement from large investors, commonly referred to as "whales." This activity indicates a largely bearish sentiment towards Mastercard. In our analysis of the recent trades involving Mastercard MA, we identified eight significant transactions. Interestingly, none of these...

Continue Reading
Coave Therapeutics Raises Significant Funding for Genetic Breakthroughs

Updated Category News Views 292

Coave Therapeutics Secures Major Investment to Propel Innovation Coave Therapeutics, a pioneer in the realm of genetic medicines, has successfully raised €32 million (approximately $33 million) in a Series A financing round. This funding was notably co-led by Novo Holdings A/S and Bpifrance, with additional contributions from leading investors in the US and EU,...

Continue Reading
Strive Expands with MSTR True North Acquisition and Leadership Change

Updated Category News Views 140

Strive's Exciting Acquisition of MSTR True North Inc. Strive, Inc. has made waves in the financial technology sector with its strategic acquisition of MSTR True North Inc. This move marks a pivotal moment in Strive's journey, enhancing its commitment to Bitcoin advocacy and marking a significant step forward in the realm of Digital Capital and Digital Credit. Leadership...

Continue Reading